A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy

BM Vanaudenaerde, I Meyts, R Vos… - European …, 2008 - Eur Respiratory Soc
Bronchiolitis obliterans syndrome (BOS) is the most important cause of late mortality
following lung transplantation, resulting in major morbidity and a huge burden on healthcare …

[HTML][HTML] Chronic lung allograft dysfunction phenotypes and treatment

SE Verleden, R Vos, BM Vanaudenaerde… - Journal of thoracic …, 2017 - ncbi.nlm.nih.gov
BM Vanaudenaerde is sponsored by the KU Leuven (C24/15/030). … Verleden GM,
Vanaudenaerde BM, Dupont LJ, et al. Azithromycin reduces airway neutrophilia and interleukin-8 in …

Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection

R Vos, BM Vanaudenaerde, SE Verleden… - …, 2012 - journals.lww.com
Chronic lung allograft rejection is the single most important cause of death in lung
transplant recipients after the first postoperative year, resulting in a 5-year survival rate of …

[HTML][HTML] Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2

…, J Wauters, E Wauters, BM Vanaudenaerde… - Nature Genetics, 2021 - nature.com
The ongoing COVID-19 pandemic has caused a global economic and health crisis. To
identify host factors essential for coronavirus infection, we performed genome-wide functional …

Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome

GM Verleden, BM Vanaudenaerde… - American journal of …, 2006 - atsjournals.org
Rationale: Bronchiolitis obliterans syndrome (BOS) remains the leading cause of death after
lung transplantation. Treatment is difficult, although azithromycin has recently been shown …

A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation

R Vos, BM Vanaudenaerde… - European …, 2011 - Eur Respiratory Soc
Azithromycin reduces airway inflammation and improves forced expiratory volume in 1 s (FEV
1 ) in chronic rejection or bronchiolitis obliterans syndrome (BOS) after lung …

The role of interleukin-17 during acute rejection after lung transplantation

BM Vanaudenaerde, LJ Dupont… - European …, 2006 - Eur Respiratory Soc
Acute rejection (AR) is an important complication that can occur after lung transplantation
and constitutes a risk factor for bronchiolitis obliterans syndrome, which is characterised by a …

[HTML][HTML] The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation

BM Vanaudenaerde, SI De Vleeschauwer… - American Journal of …, 2008 - Elsevier
BM Vanaudenaerde and SI De Vleeschauwer contributed equally to this work. GM Verleden
is … BM Vanaudenaerde and LJ Dupont are senior research fellows and R. Vos is a Ph.D. …

Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?

R Vos, BM Vanaudenaerde, N Geudens… - European …, 2008 - Eur Respiratory Soc
Airway colonisation with Pseudomonads, especially Pseudomonas aeruginosa, is common
in lung transplant (LTx) recipients. The current authors investigated whether pseudomonal …

Sinonasal pathology in nonallergic asthma and COPD:'united airway disease'beyond the scope of allergy

G Hens, BM Vanaudenaerde, DMA Bullens… - Allergy, 2008 - Wiley Online Library
Background: In contrast to the epidemiological and clinical association between allergic
rhinitis and asthma, upper airway inflammation is less characterized in patients with nonatopic …